CanWalk: a walking intervention for people with recurrent or metastatic cancer
Not Applicable
Completed
- Conditions
- Recurrent or metastatic cancerCancer
- Registration Number
- ISRCTN42072606
- Lead Sponsor
- King's College London (UK)
- Brief Summary
2015 protocol in: http://www.pilotfeasibilitystudies.com/content/1/1/7/abstract 2017 results in: http://www.ncbi.nlm.nih.gov/pubmed/28202500
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. 16 years of age or older
2. Diagnosed with metastatic or recurrent cancer in the previous 6 months
3. Able to walk for a minimum of 30 minutes unaided
Exclusion Criteria
1. Bone metastases that the clinician in charge of the patient's care considers a contra-indication to participating in the walking intervention
2. Unable to speak and understand English
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The feasibility and acceptability of a walking intervention that combines a motivational element with a pre-existing and nationally available walking programme
- Secondary Outcome Measures
Name Time Method <br> Participants will complete the following questionnaires at baseline (T0), 6 (T1), 12 (T2) and 24 (T3) weeks:<br> 1. Quality of Life (Functional Assessment of Cancer Therapy scale- General; EuroQol)<br> 2. Physical activity level (Scottish Physical Activity Questionnaire; General Practice Physical Activity Questionnaire)<br> 3. Fatigue (Brief Fatigue Inventory)<br> 4. Distress (depression anxiety stress scales)<br> 5. Exercise self-efficacy (Spinal Cord Injury, to measure exercise self-efficacy)<br><br> At baseline and 24 weeks participants? performance status will also be assessed (Eastern Cooperative Oncology Group) and the strength of their motivation to change behaviour using a brief ?ruler? (100 mm visual analogue scale)<br>